A particularly strong reduction in secreted Vascular Endothelial Growth Factor (VEGF) (a key mediator of angiogenesis and a target in cancer therapy (Carmeliet 2005)) was observed (Fig. 5E). This evidence concerns the gene VEGFA and cancer.